Sabby Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Sabby Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,944,978	Closed	-$469K	–	148
2018 Q4	$469K	Buy	+1,944,978	New	+$1.2M	0.1%	57
2018 Q1	–	Sell	-108,364	Closed	-$867K	–	221
2017 Q4	$867K	Buy	+108,364	New	+$984K	0.08%	81
2017 Q2	–	Sell	-2,041	Closed	-$51K	–	290
2017 Q1	$51K	Buy	+2,041	New	+$52.6K	﹤0.01%	247
2015 Q2	–	Sell	-1,990	Closed	-$60.1K	–	386
2015 Q1	$56K	Sell	1,990 -73	-4%	-$1.77K	﹤0.01%	280
2014 Q4	$47	Buy	+2,063	New	+$55.8K	﹤0.01%	228
2014 Q3	–	Sell	-31,400	Closed	-$905K	–	319
2014 Q2	$1.2M	Buy	+31,400	New	+$1.21M	0.05%	134

Sabby Management's IPCI Position: Q1 2019 in Review

Sabby Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 1,944,978 shares — an estimated $469K sold.

Sabby Management first reported a position in IPCI in Q2 2014 and held it in 6 quarters. The position peaked at $1.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

Sabby Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 1,944,978 Intellipharmaceuticals International Inc. shares in Q1 2019, an estimated $469K.
Sabby Management first reported a position in Intellipharmaceuticals International Inc. in Q2 2014 and held it in 6 quarters.
Sabby Management's Intellipharmaceuticals International Inc. position peaked at $1.2M in Q2 2014.
0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.